AKESF
Price
$19.58
Change
+$1.02 (+5.50%)
Updated
Jul 24 closing price
Capitalization
17.56B
RGBP
Price
$0.09
Change
-$0.00 (-0.00%)
Updated
Jul 24 closing price
Capitalization
1.84M
Interact to see
Advertisement

AKESF vs RGBP

Header iconAKESF vs RGBP Comparison
Open Charts AKESF vs RGBPBanner chart's image
AKESO
Price$19.58
Change+$1.02 (+5.50%)
Volume$6.81K
Capitalization17.56B
Regen Biopharma
Price$0.09
Change-$0.00 (-0.00%)
Volume$104.54K
Capitalization1.84M
AKESF vs RGBP Comparison Chart in %
Loading...
AKESF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKESF vs. RGBP commentary
Jul 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKESF is a Buy and RGBP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2025
Stock price -- (AKESF: $19.58 vs. RGBP: $0.09)
Brand notoriety: AKESF and RGBP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKESF: 197% vs. RGBP: 220%
Market capitalization -- AKESF: $17.56B vs. RGBP: $1.84M
AKESF [@Biotechnology] is valued at $17.56B. RGBP’s [@Biotechnology] market capitalization is $1.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKESF’s FA Score shows that 1 FA rating(s) are green whileRGBP’s FA Score has 1 green FA rating(s).

  • AKESF’s FA Score: 1 green, 4 red.
  • RGBP’s FA Score: 1 green, 4 red.
According to our system of comparison, both AKESF and RGBP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKESF’s TA Score shows that 4 TA indicator(s) are bullish while RGBP’s TA Score has 5 bullish TA indicator(s).

  • AKESF’s TA Score: 4 bullish, 4 bearish.
  • RGBP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RGBP is a better buy in the short-term than AKESF.

Price Growth

AKESF (@Biotechnology) experienced а +10.80% price change this week, while RGBP (@Biotechnology) price change was +50.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.05%. For the same industry, the average monthly price growth was +18.11%, and the average quarterly price growth was +28.55%.

Reported Earning Dates

RGBP is expected to report earnings on May 16, 2025.

Industries' Descriptions

@Biotechnology (+6.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKESF($17.6B) has a higher market cap than RGBP($1.84M). AKESF YTD gains are higher at: 179.714 vs. RGBP (22.333).
AKESFRGBPAKESF / RGBP
Capitalization17.6B1.84M954,965%
EBITDAN/A-804.74K-
Gain YTD179.71422.333805%
P/E Ratio25.37N/A-
RevenueN/A237K-
Total CashN/A1.76K-
Total DebtN/A968K-
FUNDAMENTALS RATINGS
RGBP: Fundamental Ratings
RGBP
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
99
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKESFRGBP
RSI
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
38%
Bullish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
44%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 16 days ago
67%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
45%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AKESF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SMDD14.320.36
+2.57%
ProShares UltraPro Short MidCap400
VV292.870.31
+0.11%
Vanguard Large-Cap ETF
IBIC25.71N/A
N/A
iShares iBonds Oct 2026 Term Tips ETF
FDIG39.66-0.52
-1.29%
Fidelity Crypto Industry&DgtlPymntsETF
RWK121.71-1.88
-1.53%
Invesco S&P MidCap 400 Revenue ETF

AKESF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKESF has been loosely correlated with INBX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AKESF jumps, then INBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKESF
1D Price
Change %
AKESF100%
+5.50%
INBX - AKESF
45%
Loosely correlated
-0.56%
SMMT - AKESF
27%
Poorly correlated
-1.57%
NUVL - AKESF
25%
Poorly correlated
+1.99%
BNTX - AKESF
23%
Poorly correlated
-0.03%
CPMV - AKESF
22%
Poorly correlated
N/A
More

RGBP and

Correlation & Price change

A.I.dvisor tells us that RGBP and SABS have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGBP and SABS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGBP
1D Price
Change %
RGBP100%
-2.38%
SABS - RGBP
23%
Poorly correlated
+4.42%
ASPHF - RGBP
8%
Poorly correlated
N/A
SHJBF - RGBP
8%
Poorly correlated
N/A
ROIV - RGBP
5%
Poorly correlated
-0.09%
AKESF - RGBP
4%
Poorly correlated
+5.50%
More